1. Home
  2. CPSS vs VYGR Comparison

CPSS vs VYGR Comparison

Compare CPSS & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

HOLD

Current Price

$9.81

Market Cap

210.7M

Sector

Finance

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.67

Market Cap

227.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSS
VYGR
Founded
1991
2013
Country
United States
United States
Employees
928
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
210.7M
227.2M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
CPSS
VYGR
Price
$9.81
$3.67
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.50
AVG Volume (30 Days)
30.1K
498.3K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
1.27
N/A
EPS
0.24
N/A
Revenue
$434,470,000.00
$10,135,000.00
Revenue This Year
$147.09
$34.04
Revenue Next Year
N/A
$7.92
P/E Ratio
$40.98
N/A
Revenue Growth
10.41
N/A
52 Week Low
$6.67
$2.65
52 Week High
$10.49
$5.55

Technical Indicators

Market Signals
Indicator
CPSS
VYGR
Relative Strength Index (RSI) 56.69 43.39
Support Level $9.40 $3.27
Resistance Level $10.49 $4.39
Average True Range (ATR) 0.40 0.26
MACD -0.04 -0.05
Stochastic Oscillator 42.37 27.73

Price Performance

Historical Comparison
CPSS
VYGR

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: